The Liver Imaging Reporting and Data System (LI-RADS) is a comprehensive system for
standardized imaging and reporting of hepatocellular carcinoma, endorsed by the American
College of Radiology and the American Association for the Study of Liver Diseases.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The American College of Radiology LI-RADS v2018 Core.(Available at:) (Accessed April 30, 2020)
- Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients.Radiology. 2018; 289: 816-830
- Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases.Hepatology. 2018; 68: 723-750
- Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy-a systematic review.Gastroenterology. 2019; 156: 976-986
- Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications.AJR Am J Roentgenol. 2013; 201: 993-1001
- Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR Imaging.Radiology. 2016; 281: 129-139
- Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations.Eur Radiol. 2019; 29: 5073-5081
- Hepatocellular carcinoma versus other hepatic malignancy in cirrhosis: performance of LI-RADS version 2018.Radiology. 2019; 291: 72-80
- Liver Imaging Reporting and Data System (LI-RADS) v2018: impact on categorization and hepatocellular carcinoma staging.Liver Transpl. 2019; 25: 1488-1502
- Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.J Magn Reson Imaging. 2019; 50: 746-755
- Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.Abdom Radiol (NY). 2018; 43: 13-25
- Diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS) v2017 in predicting malignant liver lesions in pediatric patients: a preliminary study.Pediatr Radiol. 2019; 49: 746-758
- Large benign hepatocellular nodules in cirrhosis due to chronic venous outflow obstruction: diagnostic confusion with hepatocellular carcinoma.Transplant Proc. 2010; 42: 4116-4118
- Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions.Int J Cardiol. 2011; 151: 268-272
- Regenerative nodules in patients with chronic Budd-Chiari syndrome: a longitudinal study using multiphase contrast-enhanced multidetector CT.Eur J Radiol. 2010; 73: 588-593
- Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation.Radiographics. 2002; 22: 847-862
- Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria.HPB (Oxford). 2019; 21: 1697-1706
- Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.Hepatology. 2008; 47: 97-104
- Any value in a specialist review of liver biopsies? Conclusions of a 4-year review.Histopathology. 2016; 69: 315-321
- LI-RADS classification and prognosis of primary liver cancers at gadoxetic acid-enhanced MRI.Radiology. 2019; 290: 388-397
- Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Hepatol Int. 2017; 11: 317-370
- Nonstandardized terminology to describe focal liver lesions in patients at risk for hepatocellular carcinoma: implications regarding clinical communication.AJR Am J Roentgenol. 2018; 210: 85-90
- Interpretive differences between patients and radiologists regarding the diagnostic confidence associated with commonly used phrases in the radiology report.AJR Am J Roentgenol. 2018; 210: 123-126
- Is terminology used effectively to convey diagnostic certainty in radiology reports?.Acad Radiol. 2003; 10: 685-688
- Differing Interpretations of Report Terminology Between Primary Care Physicians and Radiologists.J Am Coll Radiol. 2016; 13: 1525-1529.e1
- Saudi Gastroenterology Association guidelines for the diagnosis and management of hepatocellular carcinoma: summary of recommendations.Ann Saudi Med. 2006; 26: 261-265
- Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma.Ann Hepatol. 2014; 13: S4-S40
- Management of hepatocellular carcinoma: an update.Hepatology. 2011; 53: 1020-1022
- Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.Hepatology. 2005; 42: 27-34
- Chapter 2: diagnosis and surveillance.Hepatol Res. 2010; 40: 16-47
- Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features.Eur Rev Med Pharmacol Sci. 2015; 19: 2786-2797
- Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.Abdom Radiol (NY). 2018; 44: 539-548
- Intrahepatic cholangiocarcinoma in patients with cirrhosis: differentiation from hepatocellular carcinoma by using gadoxetic acid-enhanced MR imaging and dynamic CT.Radiology. 2017; 282: 771-781
- Prospective intraindividual comparison of magnetic resonance imaging with gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the liver imaging reporting and data system.Hepatology. 2018; 68: 2254-2266
- Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance.Abdom Radiol (NY). 2018; 43: 2309-2320
- Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid-enhanced MRI and focal nodular hyperplasia by CT and MRI.AJR Am J Roentgenol. 2018; 211: 347-357
- Computer-aided diagnosis program for classifying the risk of hepatocellular carcinoma on MR images following liver imaging reporting and data system (LI-RADS).J Magn Reson Imaging. 2018; 47: 710-722
- LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.Abdom Radiol (NY). 2018; 43: 75-81
- LI-RADS((R)) ancillary features on CT and MRI.Abdom Radiol (NY). 2018; 43: 82-100
- definite or probable malignancy, not specific for hepatocellular carcinoma.Abdom Radiol (NY). 2018; 43: 149-157
- Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.Hepatology. 2018; 67: 401-421
- Liver imaging reporting and data system: discordance between computed tomography and gadoxetate-enhanced magnetic resonance imaging for detection of hepatocellular carcinoma major features.J Comput Assist Tomogr. 2018; 42: 155-161
- Differences in Liver Imaging and Reporting Data System categorization between MRI and CT.AJR Am J Roentgenol. 2016; 206: 307-312
- Change in liver imaging reporting and data system characterization of focal liver lesions using gadoxetate disodium magnetic resonance imaging compared with contrast-enhanced computed tomography.J Comput Assist Tomogr. 2017; 41: 376-381
- Does a combined CT and MRI protocol enhance the diagnostic efficacy of LI-RADS in the categorization of hepatic observations? A prospective comparative study.Eur Radiol. 2018; 28: 2592-2603
- Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma.Abdom Radiol (NY). 2016; 41: 71-90
- Liver imaging reporting and data system:: substantial discordance between CT and MR for imaging classification of hepatic nodules.Acad Radiol. 2016; 23: 344-352
- Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.Eur Radiol. 2017; 27: 4394-4405
- Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.Abdom Radiol (NY). 2016; 41: 963-969
- Diagnostic performance of gadoxetic acid-enhanced liver mr imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma.Radiology. 2017; 285: 134-146
- Interreader Reliability of LI-RADS Version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study.Radiology. 2018; 286: 173-185
- The American College of Radiology LI-RADS v2018 CT/MRI Manual.(Available at:)https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf?la=en(Accessed April 30, 2020)Date: 2018
- LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features.Radiology. 2018; 288: 118-128
- Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS).J Magn Reson Imaging. 2019; 49: 1236-1252
- Chapter 13: Hepatobiliary Agents. American College of Radiology LI-RADS v2018 Manual.(Available at:) (Accessed April 30, 2020)
- Chapter 16: Imaging Features. American College of Radiology LI-RADS v2018 Manual LI-RADS v2018 Manual.(Available at:) (Accessed April 30, 2020)
- Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?.Eur Radiol. 2015; 25: 2859-2868
- Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?.Eur Radiol. 2019; 29: 1724-1732
- Diagnostic criteria for hepatocellular carcinoma 3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.J Hepatol. 2016; 64: 1099-1107
- Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS.Abdom Radiol (NY). 2019; 44: 3078-3088
- Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.Br J Radiol. 2018; 91: 20180017
- Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014.Radiology. 2018; 286: 158-172
- Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features.Liver Cancer. 2019; 8: 24-40
- Intrahepatic mass-forming cholangiocarcinoma: arterial enhancement patterns at MRI and prognosis.Radiology. 2019; 290: 691-699
- Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ.Abdom Radiol (NY). 2018; 43: 3-12
- Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?.World J Gastroenterol. 2019; 25: 622-631
- Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (</= 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.Eur Rev Med Pharmacol Sci. 2019; 23: 7786-7801
- Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3cm.J Hepatol. 2018; 68: 715-723
Article info
Publication history
Published online: June 18, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
